LON:4BB 4basebio (4BB) Share Price, News & Analysis GBX 1,100 -25.00 (-2.22%) As of 04/25/2025 12:20 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesBuy This Stock About 4basebio Stock (LON:4BB) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get 4basebio alerts:Sign Up Key Stats Today's Range 1,100▼ 1,122.5050-Day Range 1,090.50▼ 1,20552-Week Range 1,020▼ 1,820Volume693 shsAverage Volume1,077 shsMarket Capitalization£140.91 millionP/E RatioN/ADividend YieldN/APrice TargetGBX 1,600Consensus RatingBuy Company Overview4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients. Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.Read More… Receive 4BB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 4basebio and its competitors with MarketBeat's FREE daily newsletter. Email Address 4BB Stock News HeadlinesInsider Buying: 4basebio PLC (LON:4BB) Insider Purchases 2,400 Shares of StockApril 5, 2025 | insidertrades.com4basebio Plc - Director DealingApril 4, 2025 | uk.finance.yahoo.comTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…April 27, 2025 | Paradigm Press (Ad)4basebio CEO Increases Stake with Share PurchaseApril 4, 2025 | tipranks.com4basebio receives MHRA GMP licence for manufacture and supply of synthetic DNAApril 4, 2025 | msn.com4basebio Plc - 4basebio Receives GMP Licence for its UK DNA Manufacturing FacilityApril 2, 2025 | uk.finance.yahoo.com4basebio Achieves GMP Certification for UK DNA FacilityApril 2, 2025 | msn.com4basebio Plc - RBC Capital Markets initiates research coverageMarch 14, 2025 | uk.finance.yahoo.comSee More Headlines 4BB Stock Analysis - Frequently Asked Questions How have 4BB shares performed this year? 4basebio's stock was trading at GBX 1,210 at the start of the year. Since then, 4BB shares have decreased by 9.1% and is now trading at GBX 1,100. View the best growth stocks for 2025 here. How do I buy shares of 4basebio? Shares of 4BB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of 4basebio own? Based on aggregate information from My MarketBeat watchlists, some other companies that 4basebio investors own include B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Greencore Group (GNC), IQE (IQE) and Omega Diagnostics Group (ODX). Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:4BB CIKN/A Webwww.4basebio.com Phone44 1223 967 943FaxN/AEmployees101Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 1,600 High Stock Price TargetGBX 1,600 Low Stock Price TargetGBX 1,600 Potential Upside/Downside+45.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)GBX (0.78) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-9,840,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-231.29% Return on Assets-54.30% Debt Debt-to-Equity Ratio201.47 Current Ratio2.73 Quick Ratio3.52 Sales & Book Value Annual Sales£311,000.00 Price / Sales453.09 Cash FlowGBX 68.41 per share Price / Cash Flow16.08 Book ValueGBX (41) per share Price / Book-26.83Miscellaneous Outstanding Shares12,810,000Free FloatN/AMarket Cap£140.91 million OptionableNot Optionable Beta1.09 10 Stocks Set to Soar in Spring 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (LON:4BB) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 4basebio PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share 4basebio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.